Home >> Industry News >> FDA authorizes first NGS test for detecting HIV-1 DRMs

FDA authorizes first NGS test for detecting HIV-1 DRMs

image_pdfCreate PDF

The assay is validated on the Sentosa NGS workflow and has a hands-on time of less than two hours and a turnaround time of two days.

CAP TODAY
X